Middle East and Africa Brain Cancer Diagnostics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Diagnostic Type (Imaging Test, Lumbar Puncture, Biopsy, Molecular Testing, and Others); Cancer Type (Acoustic Neuroma, Astrocytoma, Craniopharyngiomas, Ganglioneuromas, Glioblastoma Multiforme, Meningiomas, Ependymomas, and Others); End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, and Others)
Market Introduction
Brain cancers are caused due to extracellular growth of the cells in the brain that causes tumors. The tumor includes primary brain tumors and secondary brain tumors. Primary brain tumors are formed in the brain and do not spread to other body parts, whereas secondary tumors, also known as metastases, are those cancers that began in another part of the body. Brain tumors are categorized into 40 major types that are further classified into two major groups, including benign, i.e., slow-growing and have less possibility to spread, and malignant, i.e., cancerous, and more likely to spread.
Thus, the increase in prevalence of brain cancer is expected to create a significant demand for brain cancer diagnostics in the coming years, which is further anticipated to drive the brain cancer diagnostics market.
The pandemic has caused disruptions to health services worldwide and has impacted the ability of countries to address and respond to critical conditions like brain cancer. In many countries, diagnostics services have been disrupted, and supply chains for key commodities have been stretched. In Africa, COVID-19 has threatened the control of major health conditions including brain cancer. As COVID-19 continues to spread in Africa, there are concerns over its impact on market, limited diagnosis, and decreased access to expert neurosurgeons further impacting the market in the region. However, as the pandemic situation overcomes, the demand for several diagnostics modalities used in brain cancer diagnosis will increase.
Get more information on this report :
Market Overview and Dynamics
The Brain cancer diagnostics market in Middle East and Africa is expected to grow from US$ 87.4 million in 2021 to US$ 237.0 million by 2028; it is estimated to grow at a CAGR of 15.3% from 2021 to 2028. The term "primary brain tumor" refers to a tumor that begins in the brain. Cancer of the brain and nervous system is the tenth highest cause of mortality in men and women. In a person's lifetime, the chances of having this form of tumor are fewer than 1%. Most primary central nervous system (CNS) malignancies are brain tumors, which account for 85% to 90% of all cases. Brain tumors can be fatal, have a severe impact on quality of life, and ultimately transform a patient's and their family's lives. Furthermore, early detection of tumors often provides more treatment options. Advanced imaging technology can pinpoint the location of brain tumors. Diagnostic tools include magnetic resonance imaging (MRI) and computed tomography (CT or CAT scan). Intraoperative MRI can also be used to guide tissue biopsy and tumor resection during surgery. Magnetic resonance spectroscopy (MRS) is used to examine the chemical characteristics of tumors. Thus, the increase in the prevalence of brain cancer highly demands brain cancer diagnostic tools.
Key Market Segments
In terms of diagnostic type, the imaging test segment accounted for the largest share of the Middle East and Africa brain cancer diagnostics market in 2020. In terms of cancer type, the glioblastoma multiforme segment accounted for the largest share of the Middle East and Africa brain cancer diagnostics market in 2020. In terms of end user, the hospitals segment accounted for the largest share of the Middle East and Africa brain cancer diagnostics market in 2020.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on the brain cancer diagnostics market in Middle East and Africa are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Thermo Fisher Scientific Inc., Siemens Healthineers A, GE Healthcare, Biocept, Inc., Koninklijke Philips N.V, Canon Medical Systems, Hitachi, Ltd., and Neusoft Medical Systems.
Reasons to buy report
- To understand the Middle East and Africa Brain cancer diagnostics market landscape and identify market segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for Middle East and Africa Brain cancer diagnostics market
- Efficiently plan M&A and partnership deals in Middle East and Africa Brain cancer diagnostics market by identifying market segments with the most promising probable sales
- Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form Middle East and Africa Brain cancer diagnostics market
- Obtain market revenue forecast for market by various segments from 2021-2028 in Middle East and Africa region.
Middle East and Africa Brain Cancer Diagnostics Market Segmentation
By Diagnostic Type
- Imaging Test
- MRI
- CT Scan
- PET
- Biopsy
- Molecular Testing
- Lumbar Puncture
- Others
By Cancer Type
- Glioblastoma Multiforme
- Astrocytomas
- Ependymomas
- Others
By End User
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers
- Others
By Country
- Middle East and Africa
- UAE
- Saudi Arabia
- South Africa
- Rest of Middle East and Africa
Companies Mentioned
- Thermo Fisher Scientific Inc.
- Siemens Healthineers A
- GE Healthcare
- Biocept, Inc.
- Koninklijke Philips N.V
- Canon Medical Systems
- Hitachi, Ltd.
- Neusoft Medical Systems
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Brain Cancer Diagnostics Market – By Diagnostic Type
1.3.2 Brain Cancer Diagnostics Market – By Cancer Type
1.3.3 Brain Cancer Diagnostics Market – By End User
1.3.4 Middle East and Africa Brain Cancer Diagnostics Market – By Country
2. Middle East and Africa Brain Cancer Diagnostics Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East and Africa Brain Cancer Diagnostics Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Brain Cancer Diagnostics Market- Middle East and Africa PEST Analysis
4.3 Expert Opinion
5. Middle East and Africa Brain Cancer Diagnostics Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increase in Prevalence of Brain Cancer
5.1.2 Rise in Number of Cigarette Smokers
5.2 Market Restraints
5.2.1 High Cost of Diagnosis
5.3 Future Trends
5.3.1 Use of Stimulated Raman Histology (SRH)Artificial Intelligence (AI) to Enhance Brain Tumor Diagnosis During Surgery
5.4 Impact Analysis
6. Brain Cancer Diagnostics Market – Middle East and Africa Analysis
6.1 Middle East and Africa Brain Cancer Diagnostics Market Revenue Forecasts and Analysis
7. Middle East and Africa Brain Cancer Diagnostics Market Analysis and Forecasts To 2028 – By Diagnostic Type
7.1 Overview
7.2 Brain Cancer Diagnostics Market Revenue Share, by Diagnostic Type (2020 and 2028)
7.3 Imaging Tests
7.3.1 Overview
7.3.2 Imaging Tests: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.3.3 MRI
7.3.3.1 Overview
7.3.3.2 MRI: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.3.4 CT Scan
7.3.4.1 Overview
7.3.4.2 CT Scan: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.3.5 Positron emission tomography (PET)
7.3.5.1 Overview
7.3.5.2 Positron emission tomography (PET): Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Lumbar Puncture
7.4.1 Overview
7.4.2 Lumbar Puncture: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Biopsy
7.5.1 Overview
7.5.2 Biopsy: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Molecular Testing
7.6.1 Overview
7.6.2 Molecular Testing: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.7 Others
7.7.1 Overview
7.7.2 Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8. Middle East and Africa Brain Cancer Diagnostics Market Analysis and Forecasts To 2028 – By Cancer Type
8.1 Overview
8.2 Brain Cancer Diagnostics Market Revenue Share, by Cancer Type (2020 and 2028)
8.3 Astrocytomas
8.3.1 Overview
8.3.2 Astrocytomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Glioblastoma Multiforme
8.4.1 Overview
8.4.2 Glioblastoma Multiforme: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Ependymomas
8.5.1 Overview
8.5.2 Ependymomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9. Brain Cancer Diagnostics Market Analysis – By End user
9.1 Overview
9.2 Brain Cancer Diagnostics Market Revenue Share, by End User (2020 and 2028)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Specialty Clinics
9.4.1 Overview
9.4.2 Specialty Clinics: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Ambulatory Surgical Centers
9.5.1 Overview
9.5.2 Ambulatory Surgical Centers: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10. Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 – Geographical Analysis
10.1 Middle East and Africa: Brain Cancer Diagnostics Market
10.1.1 Overview
10.1.2 Middle East and Africa: Brain Cancer Diagnostics Market, by Country, 2021 & 2028 (%)
10.1.2.1 Saudi Arabia: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)
10.1.2.1.1 Saudi Arabia: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)
10.1.2.1.2 Saudi Arabia Brain Cancer Diagnostics Market, by Diagnostics Type– Revenue and Forecast to 2028 (USD Million)
10.1.2.1.2.1 Saudi Arabia Brain Cancer Diagnostics Market, by Imaging Test– Revenue and Forecast to 2028 (USD Million)
10.1.2.1.3 Saudi Arabia Brain Cancer Diagnostics Market, by Cancer Type– Revenue and Forecast to 2028 (USD Million)
10.1.2.1.4 Saudi Arabia Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)
10.1.2.2 UAE: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)
10.1.2.2.1 UAE: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)
10.1.2.2.2 UAE Brain Cancer Diagnostics Market, by Diagnostics Type– Revenue and Forecast to 2028 (USD Million)
10.1.2.2.2.1 UAE Brain Cancer Diagnostics Market, by Imaging Test– Revenue and Forecast to 2028 (USD Million)
10.1.2.2.3 UAE Brain Cancer Diagnostics Market, by Cancer Type– Revenue and Forecast to 2028 (USD Million)
10.1.2.2.4 UAE Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)
10.1.2.3 South Africa: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)
10.1.2.3.1 South Africa: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)
10.1.2.3.2 South Africa Brain Cancer Diagnostics Market, by Diagnostics Type– Revenue and Forecast to 2028 (USD Million)
10.1.2.3.2.1 South Africa Brain Cancer Diagnostics Market, by Imaging Test– Revenue and Forecast to 2028 (USD Million)
10.1.2.3.3 South Africa Brain Cancer Diagnostics Market, by Cancer Type– Revenue and Forecast to 2028 (USD Million)
10.1.2.3.4 South Africa Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)
10.1.2.4 Rest of Middle East and Africa: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)
10.1.2.4.1 Rest of Middle East and Africa: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)
10.1.2.4.2 Rest of Middle East and Africa Brain Cancer Diagnostics Market, by Diagnostics Type– Revenue and Forecast to 2028 (USD Million)
10.1.2.4.2.1 Rest of Middle East and Africa Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)
10.1.2.4.3 Rest of Middle East and Africa Brain Cancer Diagnostics Market, by Cancer Type– Revenue and Forecast to 2028 (USD Million)
10.1.2.4.4 Rest of Middle East and Africa Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)
11. Impact Of COVID-19 Pandemic on Middle East and Africa Brain Cancer Diagnostics Market
11.1 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
12. Industry Landscape
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market, (%)
12.1 Organic Developments
12.1.1 Overview
12.2 Inorganic Developments
12.2.1 Overview
13. Company Profiles
13.1 THERMO FISHER SCIENTIFIC INC.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Siemens Healthineers AG
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 GE Healthcare
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Biocept, Inc.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Koninklijke Philips N.V.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Canon Medical Systems
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Hitachi, Ltd.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Neusoft Medical Systems
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
14. Appendix
14.1 About the Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. Saudi Arabia Brain Cancer Diagnostics Market, by Diagnostics Type – Revenue and Forecast to 2028 (USD Million)
Table 2. Saudi Arabia Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)
Table 3. Saudi Arabia Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)
Table 4. Saudi Arabia Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 5. UAE Brain Cancer Diagnostics Market, by Diagnostics Type – Revenue and Forecast to 2028 (USD Million)
Table 6. UAE Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)
Table 7. UAE Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)
Table 8. UAE Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 9. South Africa Brain Cancer Diagnostics Market, by Diagnostics Type – Revenue and Forecast to 2028 (USD Million)
Table 10. South Africa Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)
Table 11. South Africa Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)
Table 12. South Africa Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 13. Rest of Middle East and Africa Brain Cancer Diagnostics Market, by Diagnostics Type – Revenue and Forecast to 2028 (USD Million)
Table 14. Rest of Middle East and Africa Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)
Table 15. Rest of Middle East and Africa Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)
Table 16. Rest of Middle East and Africa Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 17. Organic Developments in the Brain Cancer Diagnostics Market
Table 18. Inorganic Developments in the Brain Cancer Diagnostics Market
Table 19. Glossary of Terms, Brain Cancer Diagnostics Market
LIST OF FIGURES
Figure 1. Brain Cancer Diagnostics Market Segmentation
Figure 2. Middle East and Africa Brain Cancer Diagnostics Market Overview
Figure 3. Imaging Test Segment Held Largest Share of Diagnostic Type in Brain Cancer Diagnostics Market
Figure 4. Saudi Arabia is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. Brain Cancer Diagnostics Market - Middle East and Africa PEST Analysis
Figure 6. Brain Cancer Diagnostics Market Impact Analysis of Driver and Restraints
Figure 7. Middle East and Africa Brain cancer diagnostics Market – Revenue Forecasts and Analysis – 2020- 2028
Figure 8. Brain Cancer Diagnostics Market Revenue Share, by Diagnostic Type (2020 and 2028)
Figure 9. Imaging Tests: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 10. MRI: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 11. CT Scan: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Positron emission tomography (PET): Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Lumbar Puncture: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Biopsy: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Molecular Testing: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Brain Cancer Diagnostics Market Revenue Share, by Cancer Type (2020 and 2028)
Figure 18. Astrocytomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Glioblastoma Multiforme: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Ependymomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Brain Cancer Diagnostics Market Revenue Share, by End User (2020 and 2028)
Figure 23. Hospitals: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Specialty Clinics: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Ambulatory Surgical Centers: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Middle East and Africa: Brain Cancer Diagnostics Market, by Key Country – Revenue (2021) (USD Million)
Figure 28. Middle East and Africa: Brain Cancer Diagnostics Market, by Country, 2021 & 2028 (%)
Figure 29. Saudi Arabia: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)
Figure 30. UAE: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)
Figure 31. South Africa: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)
Figure 32. Rest of Middle East and Africa: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)
Figure 33. Impact of COVID-19 Pandemic in Middle East and African Country Markets
Figure 34. Growth Strategies Done by the Companies in the Market, (%)
- Thermo Fisher Scientific Inc.
- Siemens Healthineers A
- GE Healthcare
- Biocept, Inc.
- Koninklijke Philips N.V
- Canon Medical Systems
- Hitachi, Ltd.
- Neusoft Medical Systems
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Middle East and Africa brain cancer diagnostics market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the Middle East and Africa brain cancer diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth Middle East and Africa market trends and outlook coupled with the factors driving the brain cancer diagnostics market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution